PATENT CLAIM ANALYSIS

Application Number: 16096505
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "001170"]

Abstract:
The present invention refers to cells from a subpopulation of progenitors of endothelial cells loaded with gold nanoparticles sensitive to excitation with infrared radiation with consequent release of thermal energy, to a composition having a plurality of these cells and to their use in the diagnosis and treatment of solid tumours thanks to the selective localization of the composition in the tumour mass, which can be thus identified easily for diagnostic purposes by marking the cells with appropriate marking agents, or treated by stimulation with pulsed laser beam up to the complete cauterization of the tumour mass for a targeted and highly effective therapeutic action.

Claim (Index 12):
The composition as defined in  claim 8 , for diagnostic and/or therapeutic agent in the diagnosis and/or treatment of a solid tumour and of possible metastases thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.53521
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13383049', '15635252', '14228540', '14388860', '14175422']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7151715791160611
- 35 USC 102 Novelty (BERT): 0.503216284214531
- Combined Prediction Score: 0.6939760496259082
- Mean Citation Score: 174.131948
- Max Citation Score: 178.88553000000005
- Similarity Product: 103.68865968452812

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test